Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10.6M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
4.26M
-
Shares change
-
-39K
-
Total reported value, excl. options
-
$9.4M
-
Value change
-
-$107K
-
Number of buys
-
11
-
Number of sells
-
-5
-
Price
-
$2.19
Significant Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q1 2024
21 filings reported holding NEPH - NEPHROS INC - Common Stock - $0.001 par value as of Q1 2024.
NEPHROS INC - Common Stock - $0.001 par value (NEPH) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.26M shares
of 10.6M outstanding shares and own 40.11% of the company stock.
Largest 10 shareholders include WEXFORD CAPITAL LP (3.6M shares), BARD ASSOCIATES INC (179K shares), VANGUARD GROUP INC (176K shares), GEODE CAPITAL MANAGEMENT, LLC (71K shares), HighTower Advisors, LLC (58.2K shares), RENAISSANCE TECHNOLOGIES LLC (41.2K shares), BLAIR WILLIAM & CO/IL (36.2K shares), ELKHORN PARTNERS LIMITED PARTNERSHIP (36K shares), STATE STREET CORP (15.7K shares), and Mesirow Financial Investment Management, Inc. (15.4K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.